Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 7072


Emerging Biological Principles of Metastasis.

Lambert AW, Pattabiraman DR, Weinberg RA.

Cell. 2017 Feb 9;168(4):670-691. doi: 10.1016/j.cell.2016.11.037. Review.


Three-dimensional collagen matrix induces a mechanosensitive invasive epithelial phenotype.

Carey SP, Martin KE, Reinhart-King CA.

Sci Rep. 2017 Feb 10;7:42088. doi: 10.1038/srep42088.


The α-ketoglutarate dehydrogenase complex in cancer metabolic plasticity.

Vatrinet R, Leone G, De Luise M, Girolimetti G, Vidone M, Gasparre G, Porcelli AM.

Cancer Metab. 2017 Feb 2;5:3. doi: 10.1186/s40170-017-0165-0. Review.


Immunomethylomic approach to explore the blood neutrophil lymphocyte ratio (NLR) in glioma survival.

Wiencke JK, Koestler DC, Salas LA, Wiemels JL, Roy RP, Hansen HM, Rice T, McCoy LS, Bracci PM, Molinaro AM, Kelsey KT, Wrensch MR, Christensen BC.

Clin Epigenetics. 2017 Feb 2;9:10. doi: 10.1186/s13148-017-0316-8.


Comprehensive Proteomic Characterization of the Human Colorectal Carcinoma Reveals Signature Proteins and Perturbed Pathways.

Hao JJ, Zhi X, Wang Y, Zhang Z, Hao Z, Ye R, Tang Z, Qian F, Wang Q, Zhu J.

Sci Rep. 2017 Feb 9;7:42436. doi: 10.1038/srep42436.


PHLPP regulates hexokinase 2-dependent glucose metabolism in colon cancer cells.

Xiong X, Wen YA, Mitov MI, C Oaks M, Miyamoto S, Gao T.

Cell Death Discov. 2017 Jan 23;3:16103. doi: 10.1038/cddiscovery.2016.103.


Inhibition of Skp2 sensitizes lung cancer cells to paclitaxel.

Huang T, Yang L, Wang G, Ding G, Peng B, Wen Y, Wang Z.

Onco Targets Ther. 2017 Jan 18;10:439-446. doi: 10.2147/OTT.S125789.


Insulin-like growth factor 1 receptor activation promotes mammary gland tumor development by increasing glycolysis and promoting biomass production.

Ter Braak B, Siezen CL, Lee JS, Rao P, Voorhoeve C, Ruppin E, van der Laan JW, van de Water B.

Breast Cancer Res. 2017 Feb 7;19(1):14. doi: 10.1186/s13058-017-0802-0.


Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway.

Liu J, Li J, Li P, Wang Y, Liang Z, Jiang Y, Li J, Feng C, Wang R, Chen H, Zhou C, Zhang J, Yang J, Liu P.

Sci Rep. 2017 Feb 7;7:42125. doi: 10.1038/srep42125.


Historical Evolution of Second-Line Therapy in Non-Small Cell Lung Cancer.

Lazzari C, Bulotta A, Ducceschi M, Viganò MG, Brioschi E, Corti F, Gianni L, Gregorc V.

Front Med (Lausanne). 2017 Jan 23;4:4. doi: 10.3389/fmed.2017.00004. Review.


Special issue: "MET as actionable target in cancer therapy".

Ma PC.

Ann Transl Med. 2017 Jan;5(1):1. doi: 10.21037/atm.2017.01.10. No abstract available.


Multi-Chemotherapeutic Schedules Containing the pan-FGFR Inhibitor ARQ 087 are Safe and Show Antitumor Activity in Different Xenograft Models.

Chilà R, Hall G T, Abbadessa G, Broggini M, Damia G.

Transl Oncol. 2017 Feb 2;10(2):153-157. doi: 10.1016/j.tranon.2016.12.003. [Epub ahead of print]


Understanding cancer complexome using networks, spectral graph theory and multilayer framework.

Rai A, Pradhan P, Nagraj J, Lohitesh K, Chowdhury R, Jalan S.

Sci Rep. 2017 Feb 3;7:41676. doi: 10.1038/srep41676.


MICA Expression Is Regulated by Cell Adhesion and Contact in a FAK/Src-Dependent Manner.

Moncayo G, Lin D, McCarthy MT, Watson AA, O'Callaghan CA.

Front Immunol. 2017 Jan 19;7:687. doi: 10.3389/fimmu.2016.00687.


Are immune checkpoint blockade monoclonal antibodies active against CNS metastases from NSCLC?-current evidence and future perspectives.

O'Kane GM, Leighl NB.

Transl Lung Cancer Res. 2016 Dec;5(6):628-636. doi: 10.21037/tlcr.2016.09.05. Review.


The epigenomic basis of common diseases.

Rodger EJ, Chatterjee A.

Clin Epigenetics. 2017 Jan 19;9:5. doi: 10.1186/s13148-017-0313-y.


Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells.

Melzer C, von der Ohe J, Lehnert H, Ungefroren H, Hass R.

Mol Cancer. 2017 Feb 1;16(1):28. doi: 10.1186/s12943-017-0595-x. Review.


Does p53 codon 72 polymorphism have a prognostic value in carcinoma of the vulva and vagina?

Qvick A, Sorbe B, Helenius G, Karlsson MG, Lillsunde Larsson G.

Med Oncol. 2017 Mar;34(3):36. doi: 10.1007/s12032-017-0893-6.


Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells.

Chung ST, Geerts D, Roseman K, Renaud A, Connelly L.

Mol Cancer. 2017 Feb 1;16(1):27. doi: 10.1186/s12943-017-0606-y.

Items per page

Supplemental Content

Support Center